Literature DB >> 3298421

The influence of S-adenosylmethionine (SAM) on prolactin in depressed patients.

C S Thomas, T Bottiglieri, J Edeh, M W Carney, E H Reynolds, B K Toone.   

Abstract

Twenty subjects entered a double-blind placebo-controlled trial of SAM in depression. Prolactin concentrations were measured before and after 14 days' treatment. There was a highly significant fall in prolactin concentrations in the SAM-treated group.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3298421     DOI： 10.1097/00004850-198704000-00001

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN： 0268-1315            Impact factor:   1.659


  4 in total

Review 1.  Folates and psychiatric disorders. Clinical potential.

Authors:  R Crellin; T Bottiglieri; E H Reynolds
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

Review 2.  Complementary and alternative medicine for the treatment of major depressive disorder.

Authors:  Richard Nahas; Osmaan Sheikh
Journal:  Can Fam Physician       Date:  2011-06       Impact factor: 3.275

Review 3.  S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research.

Authors:  Anup Sharma; Patricia Gerbarg; Teodoro Bottiglieri; Lila Massoumi; Linda L Carpenter; Helen Lavretsky; Philip R Muskin; Richard P Brown; David Mischoulon
Journal:  J Clin Psychiatry       Date:  2017-06       Impact factor: 4.384

Review 4.  S-adenosyl methionine (SAMe) for depression in adults.

Authors:  Ilaria Galizia; Lucio Oldani; Karine Macritchie; Erica Amari; Dominic Dougall; Tessa N Jones; Raymond W Lam; Guido Jacopo Massei; Lakshmi N Yatham; Allan H Young
Journal:  Cochrane Database Syst Rev       Date:  2016-10-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.